Cardiologists from 57 Countries Shed Light on the Markets for Cardiovascular Devices at TCT 2016

January 27, 2017 (PRLEAP.COM) Health News
January 27, 2017 - Vancouver, BC iData Research ( recently conducted a face-to-face survey for catheterization lab, structural heart and coronary stents during the 2016 Transcatheter Cardiovascular Therapeutics (TCT) Conference in Washington, DC. Participants included cardiac surgeons, interventional cardiologists, interventional radiologists and general practitioners. Results have shown that clinical outcomes are the main deciding factor for respondents when choosing which brand of coronary stents to use. Respondents gave reasons for choosing a particular device, including price, availability of devices and existing relationships.

"This latest report is a global survey regarding demographic trends, concerns, experiences and preferences among cardiologists," explains Dr. Kamran Zamanian, CEO of iData. "Our iData team found answers to the questions posed by major cardiovascular device manufacturers regarding what they wanted to learn from the attendees of TCT 2016."

Contact us to request a free survey sample. Our survey services have been used by the top companies in the medical, dental and pharmaceutical industries.

Respondents came from a total of 57 countries. Each country has been subsequently categorized into six distinctive geographical regions: North America, Latin America, Europe, the Middle East, Africa and Asia. Within these regions, the United States, Brazil and Argentina represented the top three countries with the most respondents.

The Global Survey on Catheterization Labs, Structural Heart and Coronary Stents by iData Research includes responses for the following questions*:
  • Concern Over Radiation Exposure
  • Missed Work Days Due to Work Related Hazards
  • Main Reason for not using TAVI in younger patients
  • Preventative Factors for TAVI vs. AVR for AFib Patients
  • Percent of AFib LAA management patients are ineligible for WATCHMAN® that could benefit from a percutaneous epicardial LAA management device
  • Percent of AFib patients intolerant or ineligible for antiarrhythmic or anticoagulant pharmaceuticals
  • Percent Paroxysmal vs. Non-Paroxysmal AFib patients
  • Stent Preferences, Bare-Metal Stents
  • Stent Preferences, Drug-Eluting Stents
  • Coronary Stent Preference Factors
  • Proximal Diameter Mismatch (1mm or greater) Statistics
  • Significant Ectasia or Aneurysm Statistics
  • Vessel Diameters (Greater than 5mm) Statistics
  • Thrombus in Vessels Statistics
  • *Results for each question are sorted globally and by region

    About iData Research Physician Surveys
    iData's Global Physician Surveys are conducted by highly trained moderators with years of experience in applying iData's rigorous methodology to ensure balanced responses and to elicit keen insight from physicians, surgeons, specialists and other medical professionals. iData's Global Physician Surveys are used to garner brand awareness, product preferences, message feedback and positioning. iData's Physician Surveys allow the inclusion of a diverse range of medical professionals in broader geographical areas. They also eliminate group bias and allow for interactive one-on-one feedback as well as flexibility to expose the respondent to interactive or static media.

    About iData Research
    iData Research ( is an international market research and consulting group focused on providing market intelligence for medical device and pharmaceutical companies. iData covers research in: Operating Room Equipment, Surgical Microscopes, Robotics and Surgical Navigation, Laparoscopy, Urology, Gynecology, Vascular Access, Endoscopy, Interventional Cardiology, Cardiac Surgery, Cardiac Rhythm Management, Electrophysiology, Ultrasound, X-Ray Imaging, Diagnostic Imaging, Oncology, Spinal Implants and VCF, Spinal MIS, Orthopedic Soft Tissue Repair and Regeneration, Orthopedic Trauma, Large & Small Joints, Anesthesiology, Wound Management, Orthopedics, Ophthalmics, Dental Operatory Equipment and more.

    Share Article